CAR-T

Anna Bielowski1, Teresa Kilian1, Sarah Vera-Cruz1

  • 1Chair for Cellular Immunotherapy, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Frontiers in immunology
|February 16, 2026
PubMed
まとめ

化学抗原受容体 (CAR) T細胞治療は多発性骨髄腫に対して有望ですが,安全管理が必要です. 抗体-薬物結合体 (ADCs) は,CAR-T細胞を排除する新しい効果的な方法を提供し,治療の安全性を高めます.

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K